Charles River Laboratories International, Inc.
Equities
CRL
US1598641074
Biotechnology & Medical Research
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
229.1 USD | -2.64% | -0.44% | -3.18% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.18% | 12.08B | |
+25.03% | 46.71B | |
+48.83% | 41.8B | |
-1.13% | 41.52B | |
-5.86% | 29.55B | |
+10.35% | 25.78B | |
-20.82% | 19.26B | |
+2.05% | 12.14B | |
+28.19% | 11.98B | |
+20.36% | 11.58B |
- Stock Market
- Equities
- CRL Stock
- News Charles River Laboratories International, Inc.
- Charles River Laboratories, Axovia Therapeutics Collaborate on Developing Rare Disease Gene Therapies